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California  92037) 
A wide spectrum of effector functions mediated by thymus-derived lympho- 
cytes (T cells) is associated with structures ceded in certain regions of the H-2 
gene complex. T-helper cells from conventional mice cooperate with bone mar- 
row-derived lymphocytes (B  cells) for the production of certain antibody re- 
spenses only when both share the IA region of H-2  (1-3).  This restriction does 
not apply between allogeneic T and B cells, when the helper T cells are tolerant 
to the H-2 haplotype of the B cells (4, 5) or are specifically depleted of alloreac- 
tive lymphocytes directed against this haplotype (6). Adoptive transfer of de- 
layed-type hypersensitivity (DTH) 1 to fowl-~/-globulin in conventional mice has 
also been shown to depend upon donor and recipient mice sharing the I  region 
of H-2  (7). The physiological interaction model is the favored, but not the only 
possible explanation for these findings (3, 8-11). 
Different from these models, specific T-cell-mediated lysis of virus-infected 
(11, 12) or chemically modified target cells in vitro is exclusively associated with 
structures coded in the K  or D regions of H-2  (9, 10, 13). Also, T-cell-mediated 
immunopathological processes in  acute lymphocytic choriomeningitis (LCM) 
(14) and T-cell-mediated antiviral protection against LCM virus (LCMV) in vivo 
can be transferred adoptively only within K-  or D-region compatible mouse 
strain  combinations, the I  region being irrelevant  (15,  and footnote 2).  The 
H-2K-coded  structure can be defined genetically in the B6t/-2 bs (Hzl70) H-2 
mutant (16). Most of the evidence explaining lysis of virus-infected cells is com- 
patible with the "altered self' idea or with a physiological interaction model. 
DTH is a  widely used assay of cell-mediated immunity which is thought to 
reflect most directly pathophysiological processes (17), especially in infectious 
diseases. The fact that generation of effector T cells for DTH to fowl~-globulin 
mapped in the I region of  H-2 seemed to contradict the finding that T-cell-medi- 
ated adoptive transfer of antiviral protection to LCMV mapped in K  and D. 
*This is publication no.  1113 from the Department of Immunopathology, Scripps Clinic and 
Research Foundation, La Jolla, California 92037. This work was supported by U. S. Public Health 
Service grant AI-07007. 
Abbreviations  used  in this paper:  DTH,  delayed-type hypersensitivity; LCM,  lymphocytic 
choriomeningitis; LCMV,  LCM virus; PFU, plaque-forming units. 
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This investigation reveals that T  cells involved in the adoptive transfer of 
LCMV-specific DTH are, in fact, associated with H-2K orD, suggesting that, at 
least in this system, the biological nature of the antigen rather than the T-cell 
function determines whether T-cell specificity is associated with the I  or with 
the K  or D region of H-2. 
Materials and Methods 
Mice.  C3H and BALB/c mice were from L. C.  Strong Research Foundation, Inc., San Diego, 
Calif.  D2.GD and A.TL were bred at the Scripps Clinic and Research Foundation from breeding 
pairs generously donated by Doctors D.  C. Shreffler, C. S. David, and R. V. Blanden (18,  19).  All 
other mice were purchased from The Jackson Laboratory. 
Virus.  The WE strain of LCMV was grown in L929 fibroblasts. The virus stock contained 1 x 
10  s plaque-forming units (PFU) per ml (20). 
Experimental Protocol for Adoptive Transfer Experiments.  The method described by Blanden 
was used (21).  Approximately 3  x  10  e PFU of LCMV in 0.03 ml were injected into the left footpad 
and 0.03 ml of control supernate from uninfected L929 fibroblasts into the right footpad of each 
mouse about 6-8 h before adoptive transfer intravenously (i.v.) of usually 1 x  108 immune spleen 
cells (Fig. 1). Donors of immune cells were injected i.v. 7 days previously with about 5 × 102 PFU of 
WE  LCMV.  In  groups  of 4-6  mice footpad  thickness was  measured  with dial  gauge  calipers 
(Schnelttaster, H.  C.  Kr6plin GmbH, Schluchtern, Hessen, Germany). The percent increase in 
footpad thickness was determined as described by Tosolini and Mires (22). The difference between 
the  average  thickness of feet challenged with  virus or with  control supernate  divided by the 
average thickness of feet of normal untreated mice times 100 yields percent increase. 
Control mice were not transfused with cells.  At no time did these controls show significant 
differences in foot swelling whether challenged with LCMV or with control L929 supernate. 
Antisera and ~"Cr Release Assay.  The sera and tests used have been described in detail (23- 
25). 
Results 
T-Cell Dependence of  Primary Footpad Swelling.  6-8 days aider injections of 
LCMV  into the footpads of nu/nu  nude mice on a  BALB/c non-H-2  genetic 
background, the nu/+  and +/÷  littermates and normal BALB/c control mice 
primary swellings of their footpads clearly demonstrated the reaction's T-cell 
dependence (Fig.  2). Nude mice failed to develop a primary footpad swelling. 
Cellular Parameters for Adoptive Transfer of DTH.  DTH to LCMV could 
not be transferred by immune spleen cells treated with AKR anti-0 C3H (Table 
I). This treatment also abrogated any virus-specific T-cell-mediated cytetoxicity 
in vitro  (Table II).  Goat anti-mouse IgG-Fab,  generously donated by Dr.  B. 
Croker, lysed about 58% of the spleen cells but did not affect the capacity to 
transfer DTH or cytotoxicity. 
Transfer of DTH was dose dependent, with respect to magnitude and time of 
onset of  the footpad swelling (Table I). In no experiment was significant immedi- 
ate-type hypersensitivity demonstrable at 3 -  6 h after transfer of immune cells 
i.v. 
The DTH response was specific; vaccinia virus~immune spleen cells did not 
cause DTH in mice given footpad injections of LCMV.  Vaccinia virus-immune 
spleen cells were lyric in vitro only for vaccinia virus but not for LCMV-infected 
targets and vice versa (Table I). 
The adoptive transfer of LCMV-specific  DTH  was significant only in H-2 
compatible donor-recipient combinations (Table III), as was the virus-specific 
cytolytic activity in vitro (Table IV). Footpad swelling in recipients of normal or 778  DTH  TO  LCMV  IS  SPECIFIC  FOR  H-2K  AND  H-2D 
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FIG.  2.  Primary footpad swelling after footpad injection of 10  6 PFU of WE LCMV. (/x) nu/ 
nu nude (BALB/c) mice, (A) nu/+  and +/+ littermates (BALB/c), (E:]) BALB/c. 
LCMV-immune H-2 compatible or incompatible spleen cells was significant (P 
<  0.05) only in recipients of 5  x  107 syngeneic immune spleen cells during the 
time interval of 2-6 days after transfer (Fig. 3). Recipients of allogeneic immune 
cells did not differ significantly  from recipients of normal allogeneic cells during 
the observation period and were no different from control mice  (not shown) 
which did not receive cells. The recipients of allogeneic immune cells developed 
primary footpad swellings from day 7 onwards, which was no different from the 
swelling  in  the  control  mice,  indicating that  these  cells  had  not  conferred 
appreciable immune protection (Fig. 3). 
The accelerated kinetics of  the adoptively  transferred DTH with a second peak 
around the time of onset of the primary footpad swelling probably reflects the 
fact that the high virus dose was not controlled by the transferred immune 
spleen cells; however, with the host's own developing immune response antigen 
was cleared more rapidly by day 8 and 9 compared with clearance in recipients of 
allogeneic immune or normal cells (P <  0.01). In other experiments where 1 x 
l0  s syngeneic immune cells were transferred this second DTH peak was not 
observed, probably because virus was eliminated earlier. 
Mapping  of the H-2  Compatibility  Requirements.  LCMV-immune spleen 
cells  from a  great  variety of H-2  original type, H-2  recombinant,  and H-2 
mutant mouse strains were assayed in various strain combinations for their 
capacities to adoptively transfer DTH (Tables III, IV, and V).  Compatibility at 
the D  region alone was sufficient for transfer of significant DTH as for B10 --* 
B10.2A(2r)  or B10.D2  ~  A. TL. Also compatibility at K  and IA  or K, IA and IB 
allowed efficient transfer of DTH  (B10.D2  --*  D2.GD;  C3H  ~  A/J; B10.Br -~ 
B10.A(2r). However, compatibility at the I  + S  regions alone was not sufficient ROLF  M.  ZINKERNAGEL  779 
TABLE  I 
T  Cell and Dose Dependence  of DTH  Reaction  to LCMV  as Measured  by Increase of Footpad 
Thickness  After  Adoptive  Transfer  of LCMV  Immune  Spleen  Cells 
Mouse strain donor*  Cell treatment* and dose  Recipient§  (H-2 haplotype) 
Percent increase  of  footpad  thickness at  time  after  transfer  (h) 
6  24  48  72 
BALB/c LCMV-im-  Normal AKR + C'  BALB/c  (H-2  d)  2 +- 211  27 ± 3¶  33 ± 5¶  27 ± 6¶ 
mune (H-2  ~)  AKR anti-~ C3H + C'  BALB/c  (H-2  ~)  2 ± 2  2 ± 2  2 ± 3  2 ± 3 
Anti-lg + C'  BALB/c  (H-2  ~)  2 ± 3  22 ± 7¶  34 ± 6¶  24 ± 2¶ 
BALB/c LCMV-im-  ]  x  10  s  BALB/c  (H-2  d)  2 ± 2  20 ± 5¶  47 -* 12~  54 ±  10~ 
mune (H-2  ~)  5 x  10  z  BALB/c  (H-2  d)  4 ± 3  12 ± 5  19 ± 2¶  48 ±  12~ 
2 x  10:  BALB/c  (H-2  ~)  2-+3  2 ± 2  6 ±2  12-'5 
None  BALB/c  (H-2 d)  2  ±  3  2  ±  3  3  ±  2  2  ±  3 
1 × los  C3H/St  (H-2  ~)  2± 2  4 ±2  7 ±6  5 +- 3 
C3H/St LCMV-immune  1 x  los  C3H/St  (H-2  ~)  2 ±  3  20 -* 5¶  62 ±  15¶  60 ±  I0¶ 
(H-2  k)  5 x  IOS  C3H/St  (["1-2 ~)  2 ±  3  8  ± 3  20 ± 5¶  50 ±  13¶ 
None  C3H/St  (1"1-2  k)  2 ± 2  2 +- 3  3 ± 2  2 +- 2 
1 × l0  s  BALB/c  (H-2  d)  2 ± 2  S ± 3  6 ~ 4  5 +- 3 
C3H/St vaccinia-virus  1 ×  los  C3H/St  (H-2  ~  )  3 ± 2  4 ± 3  3 *- 3  3 +- 2 
immune (H-2  k ) 
* Mice were infected  i.v.  with 1 x  10  s i.c.  LD~, of WE  LCMV  and spleen cells  harvested 7 days later.  Cytotoxicity was >90% on H-2 
compatible L or  J774 LCMV-infected targets,  as compared with <30% on vaccinia-infected  or normal targets. 
Percent of  trypan  blue positive  cells  after  treatment was  normal goat + C': 10%; normal AKR  + C': 9%;  AKR  anti-e  C3H + C': 46%; goat- 
anti-mouse IgG Fab + C': 66%. Cytotoxic activity  is recorded in  Table H. 
§  Recipients were challenged into  the left  foot  with 3 × 106  PFU of  WE  LCMV  and into  the right  foot  with 0.03  ml of  control  medium 6 h 
previotm to  transfusion. 
r[  Means ± SEM  of  groups of  3-5 mice. 
¶ Significantly  greater than controls  (P < 0.05). 
TABLE  II 
Cytotoxicity of Anti-O,  or Anti-Ig-Treated,  or Control LCMV  Immune  BALB/c  Spleen 
Cells Used for Transfer  Experiments 
Spleen  cells and  treatment 
Percent  5'Cr release  from  J774 targets 
LCMV  Uninfected 
30:15  3:1  30:1 
LCMV  immune* 
Normal  AKR  +  C'  100§1(  4~1  26 
AKR  anti-0  C3H  +  C'  36  30  22 
Normal  goat  serum  +  C'  10(~1  4~1  25 
Goat  anti-mouse  IgG  +  C'  10{~1  441  23 
Normal  33  30  26 
Medium  31  31  24 
*  See Table  I. 
The ratio of spleen cells to target  cells corresponds  to the viable cell numbers  before treatment. 
§  Means  _+  SEM  of triplicates. 
II  Significantly  greater  (P <  0.05) than  anti-8-treated  immune  spleen  cells or normal  spleen  cells. 
as  shown  for  C3H  --*  A.TL.  These  results  correlate  with  the  virus-specific 
cytotoxic activities measured in vitro  (Table IV) and are consistent with pre- 
vious results  (12,  13). 
The notion that only K  or D  but not/-region-coded structures are relevant for 
this in vivo restriction of DTH-T-cell effector activity is further emphasized by 
the results in Table V. B10.A(3r) immune spleen cells were able to elicit DTH in 780  DTH  TO  LCMV  IS  SPECIFIC  FOR  H-2K  AND  H-2D 
the wild type H-2K  b C57BL/6 mice, but not in B6.H-2 ~"  (Hzl), H-2K mutants, 
which are IA  and IB compatible with B10.A(3r). 
Discussion 
The primary footpad swelling resulting from a  local injection of LCMV and 
the capacity of immune spleen cells to adoptively transfer LCMV-specific DTH 
are T-cell-dependent phenomena. These results are consistent with the classi- 
cal observations of DTH in LCM made by Hotchin and Hotchin and Benson (26, 
27) and Mims and collaborators (22). They are also compatible with the great 
amount of evidence indicating that acute, fatal (12,  26,  28) LCM (14), specific 
antiviral  protection  by  LCMV-immune  spleen  cells  in  vivo,  2 and  cytotoxic 
activity in vitro (11-13)  are all predominantly or exclusively T-cell mediated (9, 
10). 
Effector T  cells involved in the adoptive transfer of LCMV-specific DTH in 
vivo are much like those that adoptively transfer antiviral protection or cytotox- 
icity in vitro in that both groups of T cells are associated with the K  and D, but 
not with the I region of H-2 (Fig. 4). This is at least circumstantial evidence that 
immunological processes leading to DTH and those involved in antiviral protec- 
tion are mediated by T cells of the same specificity. 
The clear-cut functional restriction by the H-2  gene complex itself strongly 
indicates T-cell dependence. DTH is the last  of the classical T-cell-mediated 
functions shown to be restricted by regions of the H-2  gene complex (7). The 
previously proposed postulate that H-2 restriction may represent a quite gener- 
ally applicable T-cell marker (11,  29) has so far proven to be true, at least in 
mice. 
As examined so far, all T-cell effector functions involved in immunopathologi- 
cal (acute LCM) or pathophysiological, protective (adoptive transfer of DTH and 
antiviral protection) processes are at the same time LCMV-specific and specific 
for the H-2K and H-2D haplotype they carry. This strict rule can, however, be 
overcome by virus-specific T  cells generated in  irradiated chimeras reconsti- 
tuted with  parental  bone  marrow  (30-31).  An  explanation  for the  apparent 
association of T-cell specificity with K- or D-coded cell-surface structures and its 
biological significance are subject to many speculations (32, 33). Trivial explana- 
tions  like  rejection of H-2  incompatible  cells or of allogeneic inhibition  are 
unlikely as discussed for the transfer of antiviral protection. DTH was measured 
before host verus graft reactions could occur, i.e. within 24 or 48 h after transfer, 
furthermore, F1 into parental strain combinations work very efficiently and D- 
region compatibility alone is sufficient. 
Of the two main hypotheses, neither the physiological interaction model, nor 
the altered self idea,  have so  far been proven unequivocally (9,  10). Although 
the results presented do not distinguish between these basic models, they do 
establish one new point. For adoptive transfer of DTH to LCMV-infected cells, 
K- orD-region compatibility is required, even though effector T cells involved in 
DTH to fowl-T-globulin require/-region compatibility. It seems unlikely yet 
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TABLE  III 
Adoptive Transfer of LCMV-Specific DTH  in Varwus  Strain Combinations 
Mouse  Strains 
Percent increase in footpad thickness at time 
after cell transfer (h) 
Donor* H-2 
haplotype 
I 
K  I-A I-B I-C S  D 
H-2 haplotype 
Recipients  6  24  48  72 
Experiment 1 
B10.BR  B10.BR  k  kkk  k  k  1 +  2§  7  -+ 3  54  +_ 1~I  59  _+  911 
k  kkk k  k  BALB/c  d  ddd d  d  2 +_3  3  +-3  2+_2  2  +-3 
B10.A(2r)  k  kkd  d  b  2  _+ 2  5  -+ 5  27  _+ 41  33  -+  1111 
C57BL/10  C57BL/10  b  bbb  b  b  3  +- 4  24  -+  1{~1  39  _+  1(~1  47  _+  1(~t 
b bbb b b  B10.BR  k  kkk  k  k  3  +-4  3  +-3  2  +_  3  2  +_3 
B10.A(2r)  k  kkd  d  b  2  -+ 4  14  +- 211  28 _+ 411  15  _  411 
BALB/c  BALB/c  d  ddd d  d  1 _+ 2  5  +- 5  50  -+  1511  52  -+  1~1 
d  ddd d  d  B10.BR  k  kkk  k  k  3 +- 3  3  +- 3  2 +_ 3  2  +_ 2 
B10.A  BALB/c  d  ddd d  d  2  -+ 3  10  +- 2  40 +_ 411  20  -+ 311 
k  kkd d d 
Experiment 2 
B10.D2  A.TL  s  kkk  k  d  6  _+ 2  37  -+ 311  23  _+ 511  20  _+  211 
d  ddd d  d  B10.D2  x  d  ddd d  d  3  -+ 2  12  -+ 6  50 -+  1{~  I  25  _+ 311 
B10.BR  k  kkk  k  k 
D2.GD  d  dbb  b  b  1 +_ 3  23  +- 311  41  +  ~1  21  +_ 311 
A  k  kkd  dd  4_+4  32  +-311  62+-311  32  +-411 
C3H  A.TL  s  kkk  k  d  2  +_  1  3 +- 3  5+-  2  3 +- 3 
kkkkkk  A  k  kkd  dd  5+-4  35±411  40+_  1(~1  27  +_511 
Experiment 3 
B10.A  C3H  k  kkk  k  k  2  _+ 2  20  --+ 2II  20  --_ 311  NT¶ 
k  kkd d  d  BALB/c  d  ddd d  d  3  -  2  19  -+ 411  29  _  311  NT 
B10.BR  x  C3H  k  kkk  k  k  2  _+  3  22  -* 311  21  _+  211  NT 
B10.D2  BALB/c  d  ddd d  d  2  _+  2  23  -+ 311  50  -+  1~1  NT 
k  kkk k k 
d  ddd d  d 
* Donors were infected with 5  x  102 PFU of WE LCMV i.v. 7 or 8 days previously. Cytotoxicity was 
assayed (Table IV). 
S Recipients were challenged with 3  x  106 PFU of WE LCMV into the left hind footpad and with 
0.03-ml control medium into the right hind footpad 6 h  previous to transfusion. 
§ Means _+  SEM of groups of 4-5 mice. 
It Statistically  significantly different from  controls  or  recipients  of neither K  or D  compatible 
spleen cells. 
¶  NT, not tested. 
cannot be excluded that the different techniques employed are responsible for 
the discrepancy between the fowl-v-globulin model and the results with LCMV. 
Both are T-cell-dependent phenomena that follow the kinetics of DTH reactions. 
Therefore, the differential association of DTH effector cells with the I  or, alter- 782  DTH  TO  LCMV  IS  SPECIFIC  FOR  H-2K  AND  H-2D 
TABLE IV 
Cytotoxic Activity of Spleen Cells Used For Adoptive Transfer of DTH 
Percent 51Cr release from targets$ 
Spleen cells*  C57BL/6 
(H-2 haplotype)  L cells  J774 
k  kkk k  k  d  ddd d  d  macrophages 
I  b bbb b b 
K  I-A I-B I-C S  D 
LCMV Normal  LCMV Normal  LCMV Normal 
Experiment 1 
B10  LCMV immune  12§  13  26  23  6011  35 
b bbb b b  Normal  15  14  24  23  35  35 
B10.BR  LCMV immune  48~[  14  23  22  37  34 
k  kkk k  k 
B10.A  LCMV immune  39H  14  52[]  22  36  36 
k  kkd d  d 
BALB/c  LCMV immune  12  12  6311  22  38  35 
d  ddd d  d  Normal  14  13  19  20  35  35 
Medium  14  13  22  21  36  35 
Experiment 2 
A.TL 
s kkk k  d 
LCMV immune  25  23  8~[  28 
B10.D2 x  B10.BR  LCMV immune  74[  24  94[  26 
d  ddd d  d  Normal  23  24  28  27 
k  kkk k  k 
NT¶ 
* Donor mice were immunized with 103 i.c. LD~o  of WE LCMV 7 days previously; spleens from 10- 
15 animals were pooled and tested (see Table III). 
Spleen cells were assayed at a spleen cell to target ratio of 30:1 for 8 h at 37°C. 
§ Means of triplicates.  The SEM were between 0.5 and 2.2. 
I] Significantly different from immune spleen cells on uninfected targets or normal spleen cells on 
infected target cells. 
¶ NT, not tested. 
natively,  with the K  and D  regions may prove to indicate  a  more fundamental 
difference. If the assumption is correct, that the phenomena triggered and meas- 
ured  in  both  models  are  the  same,  then  the  differences  may  reflect  the  pro- 
nounced biological differences  of the antigens  used: fowl-v-globulin and virus. 
It seems unlikely that I  or K  and D  association  of DTH effector cells  in these 
models is due to differential  expression  of self-recognizer structures  for the re- 
spective H-2  regions, dependent on the sensitizing antigen. Furthermore,  it may 
be that different subsets of T  cells are sensitized by the two antigens  (34). Since 
DTH to fowl-v-globulin is mediated by Ly-l-positive T  cells  (35) it will be inter- 
esting to determine the Ly type of the T cells eliciting DTH in the LCMV model. 
Thus  different  antigens  triggering  similar  in  vivo  phenomena  apparently 
sensitize  T  cells  differentially  in association  with  different  subregions  of H-2. 
Chemically  defined,  soluble  or  particulate  antigens  that  are  chemically  or ROLF  M.  ZINKERNAGEL  783 
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Fro.  3.  Footpad swelling in recipients of 5 × 107 syngeneic or allogeneic LCMV immune or 
normal spleen cells after injection of l0  s PFU WE LCMV into the footpad. 7 days LCMV 
immune BALB/c spleen cells into BALB/c recipients (-A-); BALB/c immune into CBA/H 
(-[]-);  CBA/H immune  into CBA/H (-©-);  CBA/H immune  into BALB/c (-V-); normal 
BALB/c into CBA/H (-0-); normal CBA/H into BALB/c (-A-). 
TABLE  V 
DTH  in the B6.H-2 b" (Hzl)  H-2 Mutant 
Donor* H-2  Recipient* H-2 
haplotype  haplotype 
Percent increase of footpad thickness at times 
after transfer (h) 
I  I 
K  I-A I-B I-C S  D  K  I-A I-B I-C S D  6  24  48  72 
B10.A(3r)§  B6.H-2 o"  4  +  31]  4  -+  2  4  _  2  4  -+  2 
b  bbd d  d  ba bbb b b 
C57BL/6  2  -  2  25  +_  2¶  53  -  3¶  15  -+  2¶ 
b bbb b b 
* Donor mice were infected with 1 ×  103 i.c.  LD~ of WE LCMV 7 days previous to transfer. 
Recipients were challenged into the left foot with 3  x  106 PFU of WE LCMV and 0.03  ml of 
control supernate into the right foot 8 h previous to transfusion. 
§ Cytotoxic activity of B10.A(3r) immune spleen cells assayed at 30:1 for 7 h caused significant (P 
<  0.05)  lysis of C57BL/6 LCMV-infected macrophage targets: 73% vs. 29-30% by normal spleen 
cells; no  significant lysis  as  compared  with  controls  was detectable  against  LCMV-infected 
B6.H-2 ~  macrophage targets. 
[I Means _  SEM of groups of 4-5 mice. 
¶ Statistically significantly greater than in B6.H-2 b". 
biologically inert  (i.e.,  nonmultiplying) or intracellular bacteria  (29, unpub- 
lished results) are passively taken up from interstitium or circulation by phago- 
cytes (36, 37). They may be handled by macrophages, blood monocytes, or other 
members of the reticuloendothelial system to become associated with structures 
coded in the I  region of H-2.  It is unclear how this may happen; a speculative 
possibility is that phagolysosomes are the processing organelles and that the 
relevant "antigen-altered"/-coded  structures are re-expressed on the cell surface 
by exocytosis (29, 36-38). 784  DTH  TO  LCMV  IS  SPECIFIC  FOR  H-2K  AND  H-2D 
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FZG. 4.  Summary  of the  genetic  requirements  as  tested  in  Tables  I,  III,  and  V.  (m) 
compatibility; ([]) incompatibility; (+) positive transfer of DTH; (-) no adoptive transfer of 
DTH. 
Multiplying infectious agents,  like viruses,  that actively invade cells and 
interfere in genetic and metabolic pathways of the host cells may, because of 
these parameters,  act quite differently and alter K-  and D-coded structures 
instead of I  structures. Altered K  or D might be envisaged as complex of viral 
antigen and K  or D  structure, as long or short range disturbances of these 
structures by budding virus, as derepression of regulatory genes determining 
multigenically defined H-2K or D  haplotype expression (though specificity is 
difficult to envisage in this model [39]), or direct or indirect (e.g., via glycosyl- 
transferases [40]) chemical modification of these self-structures. 
Such an interpretation of  the various restrictions ofT-cell effector  functions by 
the H-2  gene complex and  of the  DTH  phenomena in  particular would be 
consistent with the postulated unifying concept that T cells may be reactive in 
general (and exclusively?) to altered cell surface structures coded in the K, I, 
and D  region of H-2,  to virally altered or chemically modified H-2K or H-2D, 
antigen altered ]a, and alloantigens (8-10, 32). 
Summary 
In  mice,  primary footpad  swelling aider  local  infection with  lymphocytic 
choriomeningitis virus (LCMV) and delayed-type hypersensitivity (DTH) adop- 
tively transferred by LCMV immune lymphocytes are T-cell dependent. Nude 
mice do not develop primary footpad swelling, and T-cell depletion abrogates the 
capacity to transfer LCMV-specific  DTH. Effector T cells involved in eliciting 
dose-dependent DTH are virus specific in that vaccinia virus-immune lympho- 
cytes could not elicit DTH in LCMV-infected mice. 
The adoptive transfer of DTH is restricted to H-2K or H-2D compatible donor- 
recipient combinations. Distinct  from the fowl-y-globulin  DTH model,/-region 
compatibility is neither necessary nor alone sufficient. Whatever the mecha- 
nisms involved in this K-  or D-region associated restriction in vivo, it most 
likely operates at the level of T-cell recognition of"altered self' ceded in K or D. 
T cells associated with the I  region (helper T cells and DTH-T cells to fowl~- 
globulin) are specific for soluble, defined, and inert antigens. T cells associated 
with the K and D region (T cells cytotoxic in vitro and in vivo for acute LCMV- 
infected cells, DTH effector T cells, and anti-viral T cells) are specific for infec- 
tious, multiplying virus. The fact that T-cell specificity is differentially linked ROLF  M.  ZINKERNAGEL  785 
with the I  region or with the K  andD regions of  H-2 may reflect the fundamental 
biological  differences of these  antigens.  Although  it  cannot  be  excluded  that 
separate functional subclasses of T-effector cells could have self-recognizers for 
different cell surface structures coded in I  or K  and D, it is more likely that the 
antigen parameters determine whether T  cells are specific for "altered" I  or "al- 
tered" K- or D-coded structures. 
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